| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/14/2006 | WO2006096806A2 Treatment with statin and omega-3 fatty acids and a combination product thereof |
| 09/14/2006 | WO2006096802A1 Amorphous tegaserod maleate |
| 09/14/2006 | WO2006096785A1 Quinoxaline dihydrohalide dihydrates and synthetic methods therefor |
| 09/14/2006 | WO2006096780A2 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
| 09/14/2006 | WO2006096778A2 Polyphenol coxib combinations and methods |
| 09/14/2006 | WO2006096769A2 Use of alpha-glucosidase inhibitors to treat alphavirus infections |
| 09/14/2006 | WO2006096759A2 Methods and compositions for treating cancer |
| 09/14/2006 | WO2006096757A2 Inhibitors of reca activities for control of antibiotic-resistant bacterial pathogens |
| 09/14/2006 | WO2006096665A1 Epimerization of 4'-c bond and modification of 14-ch3-(co)-fragment in anthracyclin antibiotics |
| 09/14/2006 | WO2006096606A1 Use of pkc-activating compounds as cardioprotectants and as apoptosis-inducing anti-tumor agents |
| 09/14/2006 | WO2006096591A1 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| 09/14/2006 | WO2006096572A1 Ethambutol based nitric oxide donors |
| 09/14/2006 | WO2006096564A1 Fused aromatic compounds having anti-diabetic activity |
| 09/14/2006 | WO2006096555A1 Compositions and methods for cancer treatment |
| 09/14/2006 | WO2006096518A2 Improved gacyclidine formulations |
| 09/14/2006 | WO2006096492A2 Compositions and methods for reducing photosensitivity associated with photodynamic therapy |
| 09/14/2006 | WO2006096488A2 Composition comprising human igg2 antibody and chelating agent |
| 09/14/2006 | WO2006096481A1 Use of phenylacetyl-derivatives for the manufacture of a medicament to treat von hippel-lindau (vhl) disease |
| 09/14/2006 | WO2006096458A2 Treatment of hyperproliferative diseases with anthraquinones |
| 09/14/2006 | WO2006096444A2 Chemical compounds |
| 09/14/2006 | WO2006096435A1 Pharmaceutical compositions for the treatment and/or prevention of depression |
| 09/14/2006 | WO2006096434A2 Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
| 09/14/2006 | WO2006096404A2 Treatment of amyotrophic lateral sclerosis with norethindrone and anal0gues |
| 09/14/2006 | WO2006096398A2 Medicaments |
| 09/14/2006 | WO2006096360A1 Topical gels compositions |
| 09/14/2006 | WO2006096358A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists |
| 09/14/2006 | WO2006096338A1 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |
| 09/14/2006 | WO2006096325A1 Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin |
| 09/14/2006 | WO2006096270A1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 09/14/2006 | WO2006096269A2 Targeted gene deletions for polysaccharide slime formers |
| 09/14/2006 | WO2006096182A1 Azithromycin powder for oral suspension compositions |
| 09/14/2006 | WO2006096173A1 Pharmaceutical compositions and methods for peptide treatment |
| 09/14/2006 | WO2006096168A2 Procedure for asthmatic, and other non-invasive surgery for brain tumor cures |
| 09/14/2006 | WO2006096053A1 A method of preparing a porphyrin derivative, a porphyrin derivative, use of said porphyrin |
| 09/14/2006 | WO2006096030A1 Potassium channel opener having benzofuroindole skeleton |
| 09/14/2006 | WO2006096016A1 Pharmaceutical composition comprising migb compound for improving gastrointestinal dyskinetic diseases. |
| 09/14/2006 | WO2006095922A1 Tetrahydroisoquinoline compound and medicinal use thereof |
| 09/14/2006 | WO2006095906A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 09/14/2006 | WO2006095870A1 Photosensitizer, protein-cleaving agent, method of cleaving protein, sugar molecule-cleaving agent, method of cleaving sugar molecule, and photodynamic therapeutic agent |
| 09/14/2006 | WO2006095864A1 Anti-inflammatory agent |
| 09/14/2006 | WO2006095858A1 Composition for treating bacterial disease in the oral cavity, liquid agent for washing treatment, liquid agent for hemostasis treatment and method of treating bacterial disease in the oral cavity |
| 09/14/2006 | WO2006095844A1 Pharmaceutical preparation |
| 09/14/2006 | WO2006095836A1 Antipruritic agent for pruritus caused by multiple sclerosis |
| 09/14/2006 | WO2006095822A1 Sulfonamide compound and pharmaceutical thereof |
| 09/14/2006 | WO2006095820A1 Adhesive and adhesive patch |
| 09/14/2006 | WO2006095798A1 Anticancer composition for oral use comprising liposome containing phytosterols and prevention or treatment for cancer using the liposome |
| 09/14/2006 | WO2006095783A1 Novel hsp90 inhibitor |
| 09/14/2006 | WO2006095723A1 Antiallergic drug |
| 09/14/2006 | WO2006095713A1 Inhibitor of plasminogen activator inhibitor-1 |
| 09/14/2006 | WO2006095708A1 Porphyrin compound and use thereof |
| 09/14/2006 | WO2006095704A1 Method of treating liver cancer |
| 09/14/2006 | WO2006095675A1 Anti-atherogenic composition |
| 09/14/2006 | WO2006095671A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | WO2006095668A1 Microparticle and pharmaceutical composition |
| 09/14/2006 | WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient |
| 09/14/2006 | WO2006095636A1 Novel compound selectively activated at target site and utilization of the same |
| 09/14/2006 | WO2006095624A1 Protease inhibitor |
| 09/14/2006 | WO2006095542A1 Pharmaceutical composition comprising amine compound |
| 09/14/2006 | WO2006095363A2 Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
| 09/14/2006 | WO2006095355A1 Novel salts of boswellic acids and selectively enriched boswellic acids and processes for the same |
| 09/14/2006 | WO2006095270A1 Combination anticancer therapy or om-174 and pharmaceutical compositions therefor |
| 09/14/2006 | WO2006095268A1 Crystal forms of an imidazole derivative |
| 09/14/2006 | WO2006095263A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| 09/14/2006 | WO2006095205A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
| 09/14/2006 | WO2006095195A1 Antimicrobial compounds |
| 09/14/2006 | WO2006095187A1 Benzoxazocines and their therapeutic use |
| 09/14/2006 | WO2006095185A1 39-desmethoxy derivatives of rapamycin |
| 09/14/2006 | WO2006095183A1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/14/2006 | WO2006095178A1 Medicament and treatment for herpes simplex |
| 09/14/2006 | WO2006095173A2 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 09/14/2006 | WO2006095167A1 Appetite-influencing medicaments |
| 09/14/2006 | WO2006095159A1 (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation |
| 09/14/2006 | WO2006095150A1 Combination of a silicon containing component and a hormone |
| 09/14/2006 | WO2006095139A2 Cancer treatment using specific 3,6,9-substituted acridines |
| 09/14/2006 | WO2006095095A1 Ophthalmologic compositions and use mode thereof |
| 09/14/2006 | WO2006095085A1 Novel method for obtaining a fast-dissolving imidapril powder |
| 09/14/2006 | WO2006095074A1 Anti-smoking composition |
| 09/14/2006 | WO2006095014A1 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/14/2006 | WO2006095009A1 Amido-substituted 6-phenylphenanthridines |
| 09/14/2006 | WO2006094994A1 Use of 4-aminopyrimidines for the prevention of fungal pests novel 4-aminopyrimidines method for production thereof and agents comprising the same |
| 09/14/2006 | WO2006094971A1 Combination of interleukin-6 antagonists and antiproliferative drugs |
| 09/14/2006 | WO2006094961A1 Transdermal therapeutic system for the administration of analgesics |
| 09/14/2006 | WO2006094948A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists |
| 09/14/2006 | WO2006094942A1 Roflumilast for the treatment of diabetes mellitus |
| 09/14/2006 | WO2006094934A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 09/14/2006 | WO2006094933A1 Roflumilast for the treatment of diabetes mellitus |
| 09/14/2006 | WO2006094930A1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
| 09/14/2006 | WO2006094917A2 Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors |
| 09/14/2006 | WO2006094916A1 Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors |
| 09/14/2006 | WO2006094904A1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
| 09/14/2006 | WO2006094900A1 Carnitine-containing peritoneal dialysis solution having improved biocompatibility |
| 09/14/2006 | WO2006094843A1 Piperazine derivatives as glyt1 inhibitors |
| 09/14/2006 | WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors |
| 09/14/2006 | WO2006094840A1 Compounds |
| 09/14/2006 | WO2006094829A1 Microemulsions of cannabinoid receptor binding compounds |
| 09/14/2006 | WO2006094811A2 Use of microtubule stabilizing compounds for the treatment of lesions of cns axons |
| 09/14/2006 | WO2006094799A2 Pyridinone derivatives against malaria |
| 09/14/2006 | WO2006094764A1 Formulation for aviptadil |
| 09/14/2006 | WO2006094763A1 3,4,5-substituted piperidine compounds |
| 09/14/2006 | WO2006094737A2 Gastroresistant pharmaceutical formulations containing rifaximin |